Source: Good News Network
A ground-breaking clinical trial of a new investigational drug has been launched to help prevent and manage Type 1 diabetes, and researchers have already dosed the first patient in the world with the treatment.
The drug, which was developed by scientists Clinical Research Facility (CRF) at Cardiff and Vale University Health Board (UHB), aims to help the regrowth of insulin making ‘beta’ cells of the pancreas, which are lost in patients living with the disease.
Despite being an early phase trial, the CRF has now dosed two patients with this new drug.Type 1 diabetes is a serious, lifelong condition where blood glucose levels are too high because the body cannot make a hormone called insulin. Those with Type 1 diabetes are dependent on insulin but if this clinical trial works, the regrowth – or regeneration – of beta cells may mean those with Type 1 diabetes becoming far less dependent on insulin injections. The benefits of the new drug would reduce lifelong conditions and complications associated with the chronic disease.
RELATED: Scientists Have Developed a ‘Breakthrough’ That May Defeat Antibiotic-Resistant…
The post ‘Groundbreaking’ Type 1 Diabetes Drug Has Just Been Trialed on First Human Patients–With No Side Effects appeared first on FeedBox.